Pfizer: A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS.
https://media.tghn.org/med...
8.3.5. - Exposure During Pregnancy or Breastfeeding, and Occupational Exposure.
The following is detailed, and far worse. This is universal, and very bad.
https://fromthetrencheswor...
Pfizer: Protocol Title: Genetherapy, Open-label, Dose-escalation Study of PF-06838435 (SPK-9001) [adeno-associated viral vector with human factor IX gene] insubjects with hemophilia B
.GOV Prot_001: https://clinicaltrials.gov...
https://media.tghn.org/med...
8.3.5. - Exposure During Pregnancy or Breastfeeding, and Occupational Exposure.
The following is detailed, and far worse. This is universal, and very bad.
https://fromthetrencheswor...
Pfizer: Protocol Title: Genetherapy, Open-label, Dose-escalation Study of PF-06838435 (SPK-9001) [adeno-associated viral vector with human factor IX gene] insubjects with hemophilia B
.GOV Prot_001: https://clinicaltrials.gov...
09:27 PM - May 01, 2021
Only people mentioned by Feiko_0 in this post can reply